Vanguard Capital Management’s Dermata Therapeutics DRMA Stock Holding History
Bought
Maintained
Sold
Other funds holding DRMA
Vanguard Capital Management's DRMA Position: Q3 2026 in Review
Vanguard Capital Management opened a new position in Dermata Therapeutics (DRMA) in Q3 2026: 5,438 shares worth $5.98K. The stake represents ﹤0.01% of the portfolio and ranks #4037 among its holdings.
15 funds tracked by Wall St. Rank hold DRMA as of Q3 2026.
- Vanguard Capital Management held 5,438 shares of Dermata Therapeutics worth $5.98K as of Q3 2026.
- Dermata Therapeutics was a new Vanguard Capital Management position in Q3 2026.
- Dermata Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4037 holding.
- 15 funds tracked by Wall St. Rank held Dermata Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.